Foster City, India
MEDGENOME, founded in 2013, has emerged as a leader in the fields of Biotechnology and Health Care, primarily offering comprehensive genetic testing services, genomics research, and drug discovery solutions. Their headquarters is located in India, where they operate South Asia's largest CAP-accredited genetic testing laboratory.
The company specializes in a wide array of diagnostics covering rare inherited disorders, oncology, reproductive health, infectious diseases, and preventive wellness. By leveraging next-generation sequencing technologies integrated with proprietary assays and AI-enabled bioinformatics, MEDGENOME promises high-quality genomic insights for clinical decision-making.
Their strategic focus on affordability and accessibility, combined with a robust research foundation underscored by numerous peer-reviewed publications, makes them an attractive proposition for stakeholders. Notably, their recent Series D investment round totaled $50.00M, backed by investors such as Novo Holdings, LeapFrog Investments, and Sofina, illustrating strong market confidence in their potential.
Pierian
